These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 24102322

  • 1. Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combination.
    Landy SH, Cady RK, Nelsen A, White J, Runken MC.
    Headache; 2014 Apr; 54(4):640-54. PubMed ID: 24102322
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes.
    Landy S, DeRossett SE, Rapoport A, Rothrock J, Ames MH, McDonald SA, Burch SP.
    MedGenMed; 2007 Jun 07; 9(2):53. PubMed ID: 17955107
    [Abstract] [Full Text] [Related]

  • 5. Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence.
    Winner P, Linder S, Hershey AD.
    Headache; 2015 Apr 07; 55(4):519-28. PubMed ID: 25881677
    [Abstract] [Full Text] [Related]

  • 6. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.
    Headache; 2014 Jan 07; 54(1):67-79. PubMed ID: 24021029
    [Abstract] [Full Text] [Related]

  • 7. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
    Silberstein SD, Mannix LK, Goldstein J, Couch JR, Byrd SC, Ames MH, McDonald SA, Lener SE, Toso C.
    Neurology; 2008 Jul 08; 71(2):114-21. PubMed ID: 18606965
    [Abstract] [Full Text] [Related]

  • 8. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
    Silberstein S, Winner PK, McAllister PJ, Tepper SJ, Halker R, Mahmoud RA, Siffert J.
    Headache; 2017 Jun 08; 57(6):862-876. PubMed ID: 28497569
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study.
    Lipton RB, Dodick DW, Adelman JU, Kaniecki RG, Lener SE, White JD, Nelsen AC.
    Cephalalgia; 2009 Aug 08; 29(8):826-36. PubMed ID: 19220307
    [Abstract] [Full Text] [Related]

  • 14. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents.
    McDonald SA, Hershey AD, Pearlman E, Lewis D, Winner PK, Rothner D, Linder SL, Runken MC, Richard NE, Derosier FJ.
    Headache; 2011 Oct 08; 51(9):1374-87. PubMed ID: 21797863
    [Abstract] [Full Text] [Related]

  • 15. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
    Law S, Derry S, Moore RA.
    Cochrane Database Syst Rev; 2016 Apr 20; 4(4):CD008541. PubMed ID: 27096438
    [Abstract] [Full Text] [Related]

  • 16. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
    Runken MC, Goodwin B, Shah M, Eaddy M, D'Souza A, Bowers B, Bell CF.
    Appl Health Econ Health Policy; 2015 Feb 20; 13(1):109-20. PubMed ID: 25294555
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function.
    Edwards KR, Rosenthal BL, Farmer KU, Cady RK, Browning R.
    Headache; 2013 Apr 20; 53(4):656-64. PubMed ID: 23406052
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.
    Headache; 2005 Sep 20; 45(8):983-91. PubMed ID: 16109111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.